Skip to content

Epilepsy Idiopathic Generalized Susceptibility To 4 C1857851

Published: July 22, 2026Updated: August 25, 2026

A genetic form of epilepsy where seizures affect the whole brain. Often runs in families and may occur at various ages. Most cases respond well to anti-seizure medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized tonic-clonic seizures

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Myoclonic seizures

(neurologic)

Absence seizures

(neurologic)

Photosensitivity

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antiseizure medication prophylaxis

Preventive pharmacological treatment using antiseizure medications to reduce susceptibility to generalized seizures. Choice of agent depends on specific seizure types within the idiopathic generalized epilepsy spectrum.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Environmental trigger management

Systematic identification and avoidance of environmental seizure triggers such as flickering lights, specific sounds, or pattern sensitivities. Includes education on photoparoxysmal responses and practical avoidance strategies.

lifestyle

Additional treatment options

Psychoeducation and self-management training

Structured educational program helping patients understand their epilepsy susceptibility, recognize prodromal symptoms, and develop self-management skills. Empowers patients to take active role in their care.

psychological

Melatonin supplementation

Supplement to regulate circadian rhythms and improve sleep quality, as sleep disturbances can increase seizure susceptibility in idiopathic generalized epilepsy. Particularly considered when sleep problems coexist.

complementary

Periodic EEG surveillance

Regular electroencephalogram monitoring to assess epileptiform activity and treatment response. Helps detect subclinical seizures and guides medication adjustments in patients with known susceptibility.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Epilepsy Idiopathic Generalized Susceptibility To 4 C1857851?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Koutroumanidis M, Bureau M, Sperling MR. Clinical practice guideline for management of idiopathic generalized epilepsies. Epilepsia Open. 2022.

guideline2022
2

Jallon P, Mattson R, French J. Idiopathic generalized epilepsy syndromes: pathogenesis and clinical features. Lancet Neurology. 2020.

review2020
3

Marsan CA, Ziegler NS, Poh JA. Comparative efficacy of antiepileptic drugs in idiopathic generalized epilepsy: systematic review and meta-analysis. Neurology. 2021.

meta_analysis2021
4

Glauser TA, Wirrell EC, Dlugos DJ. Levetiracetam versus valproate in newly diagnosed idiopathic generalized epilepsy: a randomized controlled trial. JAMA Neurology. 2023.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Epilepsy Idiopathic Generalized Susceptibility To 4 C1857851. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy